Latest News

Joshi said the government is holding internal discussions on the draft of the Insurance Bill, which includes composite licensing Read More ​ Joshi said the government is holding internal discussions on the draft of the Insurance Bill, which includes composite licensing… Read More »Govt may infuse capital in 3 public insurers in FY25, says DFS Secy Vivek Joshi

According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones. Read More ​ According to Joshi, while fintechs are very good… Read More »Start-ups must balance growth and compliance with regulations: DFS Secy Joshi

According to Joshi, while fintechs are very good with technology and in innovating, they must be mindful of their regulatory responsibilities as they grow from small firms to larger ones. Read More ​ According to Joshi, while fintechs are very good… Read More »Start-ups must balance growth and compliance with regulations: DFS Secy Joshi

Semgalutide has almost 66 percent of the market share in the anti-obesity segment. Read More ​ Semgalutide has almost 66 percent of the market share in the anti-obesity segment. Semgalutide has almost 66 percent of the market share in the anti-obesity… Read More »Riding on Novo Nordisk’s semaglutide, India’s weight-loss market triples in size in 2 years

Sitharaman#39;s remarks comes months after the International Monetary Fund (IMF), while releasing a set of projections, flagged the possibility of India#39;s general government debt exceeding 100 percent of GDP Read More ​ Sitharaman#39;s remarks comes months after the International Monetary Fund… Read More »India#39;s debt-to-GDP ratio well below emerging markets, IMF gave worst-case scenario: FM Sitharaman

Fortis had reported a net profit of Rs 142 crore in the same quarter of the previous year Read More ​ Fortis had reported a net profit of Rs 142 crore in the same quarter of the previous year Fortis had… Read More »Fortis Healthcare Q3 results: Net profit declines 5.6% to Rs 134 crore

Motilal Oswal recommended Neutral rating on Relaxo Footwears with a target price of Rs 850 in its research report dated January 31, 2024. Read More ​ Motilal Oswal recommended Neutral rating on Relaxo Footwears with a target price of Rs 850… Read More »Neutral Relaxo Footwears; target of Rs 850 : Motilal Oswal

Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene and Health Care with a target price of Rs 16,000 in its research report dated January 31, 2024. Read More ​ Motilal Oswal recommended Neutral rating on Procter and Gamble Hygiene… Read More »Neutral Procter and Gamble Hygiene and Health Care; target of Rs 16,000 : Motilal Oswal

Motilal Oswal recommended Neutral rating on Shree Cement with a target price of Rs 27,700 in its research report dated January 31, 2024. Read More ​ Motilal Oswal recommended Neutral rating on Shree Cement with a target price of Rs 27,700… Read More »Neutral Shree Cement; target of Rs 27,700 : Motilal Oswal

Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 500 in its research report dated February 01, 2024. Read More ​ Motilal Oswal recommended Neutral rating on Jyothy Laboratories with a target price of Rs 500… Read More »Neutral Jyothy Laboratories; target of Rs 500: Motilal Oswal